J. Young

Publications459
h-index55
Citations9,755
Highly Influential Citations377
Claim Author Page
Author pages are created from data sourced from our academic publisher partnerships and public sources.

Recommended Authors

  • P. Chanson
  • 460 Publications, 14,682 Citations
  • N. Pitteloud
  • 174 Publications, 7,954 Citations
  • W. Crowley
  • 344 Publications, 26,711 Citations
  • R. Quinton
  • 288 Publications, 7,010 Citations
  • Publications
  • Influence
Loss-of-function mutations in FGFR1 cause autosomal dominant Kallmann syndrome
We took advantage of overlapping interstitial deletions at chromosome 8p11–p12 in two individuals with contiguous gene syndromes and defined an interval of roughly 540 kb associated with a dominant… Expand
  • 697
  • 36
Kallmann Syndrome: Mutations in the Genes Encoding Prokineticin-2 and Prokineticin Receptor-2
Kallmann syndrome combines anosmia, related to defective olfactory bulb morphogenesis, and hypogonadism due to gonadotropin-releasing hormone deficiency. Loss-of-function mutations in KAL1 and FGFR1… Expand
  • 379
  • 24
  • PDF
Expert consensus document: European Consensus Statement on congenital hypogonadotropic hypogonadism—pathogenesis, diagnosis and treatment
Congenital hypogonadotropic hypogonadism (CHH) is a rare disorder caused by the deficient production, secretion or action of gonadotropin-releasing hormone (GnRH), which is the master hormone… Expand
  • 349
  • 17
  • PDF
Loss-of-function mutations in SOX10 cause Kallmann syndrome with deafness.
Transcription factor SOX10 plays a role in the maintenance of progenitor cell multipotency, lineage specification, and cell differentiation and is a major actor in the development of the neural… Expand
  • 133
  • 12
Mutations in FGF17, IL17RD, DUSP6, SPRY4, and FLRT3 are identified in individuals with congenital hypogonadotropic hypogonadism.
Congenital hypogonadotropic hypogonadism (CHH) and its anosmia-associated form (Kallmann syndrome [KS]) are genetically heterogeneous. Among the >15 genes implicated in these conditions, mutations in… Expand
  • 158
  • 10
  • PDF
TAC3 and TACR3 defects cause hypothalamic congenital hypogonadotropic hypogonadism in humans.
CONTEXT Missense loss-of-function mutations in TAC3 and TACR3, the genes encoding neurokinin B and its receptor NK3R, respectively, were recently discovered in kindreds with nonsyndromic normosmic… Expand
  • 192
  • 9
Mitotane, metyrapone, and ketoconazole combination therapy as an alternative to rescue adrenalectomy for severe ACTH-dependent Cushing's syndrome.
CONTEXT Mitotane is highly effective in the long-term management of Cushing's syndrome but has a slow onset of action. Mitotane combined with fast-acting steroidogenesis inhibitors might avoid the… Expand
  • 141
  • 8
Germline AIP mutations in apparently sporadic pituitary adenomas: prevalence in a prospective single-center cohort of 443 patients.
CONTEXT Germline mutations of the AIP (aryl-hydrocarbon receptor interacting protein) gene are associated with a predisposition to pituitary adenomas. Such mutations are found in about half of… Expand
  • 115
  • 8
Testicular anti-mullerian hormone secretion is stimulated by recombinant human FSH in patients with congenital hypogonadotropic hypogonadism.
Serum anti-Mullerian hormone (AMH), a prepubertal Sertoli cell marker, declines during puberty as an early sign of testicular testosterone (T) production. When T synthesis or action is impaired,… Expand
  • 112
  • 8
New NOBOX mutations identified in a large cohort of women with primary ovarian insufficiency decrease KIT-L expression.
CONTEXT Primary ovarian insufficiency (POI) is a major cause of anovulation and infertility in women. This disease affects 1% of women before 40 years, and several genetic causes have been reported.… Expand
  • 31
  • 8